Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03470077Phase 2Completed
A Phase 2 trial of nalbuphine in Emergence agitation (EA), sponsored by Assiut University. Started Jul 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03470077.